Bio-coupling Drug Outsourcing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

TABLE OF CONTENTS

1 Market Overview

• 1.1 Bio-coupling Drug Outsourcing Services Product Introduction
• 1.2 Global Bio-coupling Drug Outsourcing Services Market Size Forecast (2020-2031)
• 1.3 Bio-coupling Drug Outsourcing Services Market Trends & Drivers
  • 1.3.1 Bio-coupling Drug Outsourcing Services Industry Trends
  • 1.3.2 Bio-coupling Drug Outsourcing Services Market Drivers & Opportunity
  • 1.3.3 Bio-coupling Drug Outsourcing Services Market Challenges
  • 1.3.4 Bio-coupling Drug Outsourcing Services Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Bio-coupling Drug Outsourcing Services Players Revenue Ranking (2024)
• 2.2 Global Bio-coupling Drug Outsourcing Services Revenue by Company (2020-2025)
• 2.3 Key Companies Bio-coupling Drug Outsourcing Services Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies Bio-coupling Drug Outsourcing Services Product Offered
• 2.5 Key Companies Time to Begin Mass Production of Bio-coupling Drug Outsourcing Services
• 2.6 Bio-coupling Drug Outsourcing Services Market Competitive Analysis
  • 2.6.1 Bio-coupling Drug Outsourcing Services Market Concentration Rate (2020-2025)
  • 2.6.2 Global 5 and 10 Largest Companies by Bio-coupling Drug Outsourcing Services Revenue in 2024
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio-coupling Drug Outsourcing Services as of 2024)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Antibody Drug Coupling Outsourcing Services
  • 3.1.2 Dual Anticoupling Material Outsourcing Services
  • 3.1.3 Antibody Oligonucleotide Coupling Outsourcing Services
  • 3.1.4 Others
• 3.2 Global Bio-coupling Drug Outsourcing Services Sales Value by Type
  • 3.2.1 Global Bio-coupling Drug Outsourcing Services Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Bio-coupling Drug Outsourcing Services Sales Value, by Type (2020-2031)
  • 3.2.3 Global Bio-coupling Drug Outsourcing Services Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Tumor Treatment
  • 4.1.2 Autoimmune Disease Treatment
  • 4.1.3 Treatment of Metabolic Disorders
  • 4.1.4 Others
• 4.2 Global Bio-coupling Drug Outsourcing Services Sales Value by Application
  • 4.2.1 Global Bio-coupling Drug Outsourcing Services Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Bio-coupling Drug Outsourcing Services Sales Value, by Application (2020-2031)
  • 4.2.3 Global Bio-coupling Drug Outsourcing Services Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

• 5.1 Global Bio-coupling Drug Outsourcing Services Sales Value by Region
  • 5.1.1 Global Bio-coupling Drug Outsourcing Services Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Bio-coupling Drug Outsourcing Services Sales Value by Region (2020-2025)
  • 5.1.3 Global Bio-coupling Drug Outsourcing Services Sales Value by Region (2026-2031)
  • 5.1.4 Global Bio-coupling Drug Outsourcing Services Sales Value by Region (%), (2020-2031)
• 5.2 North America
  • 5.2.1 North America Bio-coupling Drug Outsourcing Services Sales Value, 2020-2031
  • 5.2.2 North America Bio-coupling Drug Outsourcing Services Sales Value by Country (%), 2024 VS 2031
• 5.3 Europe
  • 5.3.1 Europe Bio-coupling Drug Outsourcing Services Sales Value, 2020-2031
  • 5.3.2 Europe Bio-coupling Drug Outsourcing Services Sales Value by Country (%), 2024 VS 2031
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Bio-coupling Drug Outsourcing Services Sales Value, 2020-2031
  • 5.4.2 Asia Pacific Bio-coupling Drug Outsourcing Services Sales Value by Region (%), 2024 VS 2031
• 5.5 South America
  • 5.5.1 South America Bio-coupling Drug Outsourcing Services Sales Value, 2020-2031
  • 5.5.2 South America Bio-coupling Drug Outsourcing Services Sales Value by Country (%), 2024 VS 2031
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Bio-coupling Drug Outsourcing Services Sales Value, 2020-2031
  • 5.6.2 Middle East & Africa Bio-coupling Drug Outsourcing Services Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Bio-coupling Drug Outsourcing Services Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Bio-coupling Drug Outsourcing Services Sales Value, 2020-2031
• 6.3 United States
  • 6.3.1 United States Bio-coupling Drug Outsourcing Services Sales Value, 2020-2031
  • 6.3.2 United States Bio-coupling Drug Outsourcing Services Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Bio-coupling Drug Outsourcing Services Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Bio-coupling Drug Outsourcing Services Sales Value, 2020-2031
  • 6.4.2 Europe Bio-coupling Drug Outsourcing Services Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Bio-coupling Drug Outsourcing Services Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Bio-coupling Drug Outsourcing Services Sales Value, 2020-2031
  • 6.5.2 China Bio-coupling Drug Outsourcing Services Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Bio-coupling Drug Outsourcing Services Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Bio-coupling Drug Outsourcing Services Sales Value, 2020-2031
  • 6.6.2 Japan Bio-coupling Drug Outsourcing Services Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Bio-coupling Drug Outsourcing Services Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Bio-coupling Drug Outsourcing Services Sales Value, 2020-2031
  • 6.7.2 South Korea Bio-coupling Drug Outsourcing Services Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Bio-coupling Drug Outsourcing Services Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Bio-coupling Drug Outsourcing Services Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Bio-coupling Drug Outsourcing Services Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Bio-coupling Drug Outsourcing Services Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Bio-coupling Drug Outsourcing Services Sales Value, 2020-2031
  • 6.9.2 India Bio-coupling Drug Outsourcing Services Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Bio-coupling Drug Outsourcing Services Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Lonza
  • 7.1.1 Lonza Profile
  • 7.1.2 Lonza Main Business
  • 7.1.3 Lonza Bio-coupling Drug Outsourcing Services Products, Services and Solutions
  • 7.1.4 Lonza Bio-coupling Drug Outsourcing Services Revenue (US$ Million) & (2020-2025)
  • 7.1.5 Lonza Recent Developments
• 7.2 BSP Pharmaceuticals
  • 7.2.1 BSP Pharmaceuticals Profile
  • 7.2.2 BSP Pharmaceuticals Main Business
  • 7.2.3 BSP Pharmaceuticals Bio-coupling Drug Outsourcing Services Products, Services and Solutions
  • 7.2.4 BSP Pharmaceuticals Bio-coupling Drug Outsourcing Services Revenue (US$ Million) & (2020-2025)
  • 7.2.5 BSP Pharmaceuticals Recent Developments
• 7.3 Catalent
  • 7.3.1 Catalent Profile
  • 7.3.2 Catalent Main Business
  • 7.3.3 Catalent Bio-coupling Drug Outsourcing Services Products, Services and Solutions
  • 7.3.4 Catalent Bio-coupling Drug Outsourcing Services Revenue (US$ Million) & (2020-2025)
  • 7.3.5 Catalent Recent Developments
• 7.4 Merck
  • 7.4.1 Merck Profile
  • 7.4.2 Merck Main Business
  • 7.4.3 Merck Bio-coupling Drug Outsourcing Services Products, Services and Solutions
  • 7.4.4 Merck Bio-coupling Drug Outsourcing Services Revenue (US$ Million) & (2020-2025)
  • 7.4.5 Merck Recent Developments
• 7.5 WuXi XDC Cayman Inc
  • 7.5.1 WuXi XDC Cayman Inc Profile
  • 7.5.2 WuXi XDC Cayman Inc Main Business
  • 7.5.3 WuXi XDC Cayman Inc Bio-coupling Drug Outsourcing Services Products, Services and Solutions
  • 7.5.4 WuXi XDC Cayman Inc Bio-coupling Drug Outsourcing Services Revenue (US$ Million) & (2020-2025)
  • 7.5.5 WuXi XDC Cayman Inc Recent Developments
• 7.6 Thermo Fisher Scientific
  • 7.6.1 Thermo Fisher Scientific Profile
  • 7.6.2 Thermo Fisher Scientific Main Business
  • 7.6.3 Thermo Fisher Scientific Bio-coupling Drug Outsourcing Services Products, Services and Solutions
  • 7.6.4 Thermo Fisher Scientific Bio-coupling Drug Outsourcing Services Revenue (US$ Million) & (2020-2025)
  • 7.6.5 Thermo Fisher Scientific Recent Developments
• 7.7 Samsung Biologics
  • 7.7.1 Samsung Biologics Profile
  • 7.7.2 Samsung Biologics Main Business
  • 7.7.3 Samsung Biologics Bio-coupling Drug Outsourcing Services Products, Services and Solutions
  • 7.7.4 Samsung Biologics Bio-coupling Drug Outsourcing Services Revenue (US$ Million) & (2020-2025)
  • 7.7.5 Samsung Biologics Recent Developments
• 7.8 Recipharm
  • 7.8.1 Recipharm Profile
  • 7.8.2 Recipharm Main Business
  • 7.8.3 Recipharm Bio-coupling Drug Outsourcing Services Products, Services and Solutions
  • 7.8.4 Recipharm Bio-coupling Drug Outsourcing Services Revenue (US$ Million) & (2020-2025)
  • 7.8.5 Recipharm Recent Developments
• 7.9 Axplora
  • 7.9.1 Axplora Profile
  • 7.9.2 Axplora Main Business
  • 7.9.3 Axplora Bio-coupling Drug Outsourcing Services Products, Services and Solutions
  • 7.9.4 Axplora Bio-coupling Drug Outsourcing Services Revenue (US$ Million) & (2020-2025)
  • 7.9.5 Axplora Recent Developments
• 7.10 Sterling Pharmaceuticals,
  • 7.10.1 Sterling Pharmaceuticals, Profile
  • 7.10.2 Sterling Pharmaceuticals, Main Business
  • 7.10.3 Sterling Pharmaceuticals, Bio-coupling Drug Outsourcing Services Products, Services and Solutions
  • 7.10.4 Sterling Pharmaceuticals, Bio-coupling Drug Outsourcing Services Revenue (US$ Million) & (2020-2025)
  • 7.10.5 Sterling Pharmaceuticals, Recent Developments
• 7.11 NJ Bio, Inc
  • 7.11.1 NJ Bio, Inc Profile
  • 7.11.2 NJ Bio, Inc Main Business
  • 7.11.3 NJ Bio, Inc Bio-coupling Drug Outsourcing Services Products, Services and Solutions
  • 7.11.4 NJ Bio, Inc Bio-coupling Drug Outsourcing Services Revenue (US$ Million) & (2020-2025)
  • 7.11.5 NJ Bio, Inc Recent Developments
• 7.12 Piramal Grangemouth
  • 7.12.1 Piramal Grangemouth Profile
  • 7.12.2 Piramal Grangemouth Main Business
  • 7.12.3 Piramal Grangemouth Bio-coupling Drug Outsourcing Services Products, Services and Solutions
  • 7.12.4 Piramal Grangemouth Bio-coupling Drug Outsourcing Services Revenue (US$ Million) & (2020-2025)
  • 7.12.5 Piramal Grangemouth Recent Developments
• 7.13 Abzena
  • 7.13.1 Abzena Profile
  • 7.13.2 Abzena Main Business
  • 7.13.3 Abzena Bio-coupling Drug Outsourcing Services Products, Services and Solutions
  • 7.13.4 Abzena Bio-coupling Drug Outsourcing Services Revenue (US$ Million) & (2020-2025)
  • 7.13.5 Abzena Recent Developments
• 7.14 Fleet Bioprocessing
  • 7.14.1 Fleet Bioprocessing Profile
  • 7.14.2 Fleet Bioprocessing Main Business
  • 7.14.3 Fleet Bioprocessing Bio-coupling Drug Outsourcing Services Products, Services and Solutions
  • 7.14.4 Fleet Bioprocessing Bio-coupling Drug Outsourcing Services Revenue (US$ Million) & (2020-2025)
  • 7.14.5 Fleet Bioprocessing Recent Developments
• 7.15 MabPlex international
  • 7.15.1 MabPlex international Profile
  • 7.15.2 MabPlex international Main Business
  • 7.15.3 MabPlex international Bio-coupling Drug Outsourcing Services Products, Services and Solutions
  • 7.15.4 MabPlex international Bio-coupling Drug Outsourcing Services Revenue (US$ Million) & (2020-2025)
  • 7.15.5 MabPlex international Recent Developments
• 7.16 Toyo Pharm
  • 7.16.1 Toyo Pharm Profile
  • 7.16.2 Toyo Pharm Main Business
  • 7.16.3 Toyo Pharm Bio-coupling Drug Outsourcing Services Products, Services and Solutions
  • 7.16.4 Toyo Pharm Bio-coupling Drug Outsourcing Services Revenue (US$ Million) & (2020-2025)
  • 7.16.5 Toyo Pharm Recent Developments
• 7.17 Aobak
  • 7.17.1 Aobak Profile
  • 7.17.2 Aobak Main Business
  • 7.17.3 Aobak Bio-coupling Drug Outsourcing Services Products, Services and Solutions
  • 7.17.4 Aobak Bio-coupling Drug Outsourcing Services Revenue (US$ Million) & (2020-2025)
  • 7.17.5 Aobak Recent Developments
• 7.18 Asymchem
  • 7.18.1 Asymchem Profile
  • 7.18.2 Asymchem Main Business
  • 7.18.3 Asymchem Bio-coupling Drug Outsourcing Services Products, Services and Solutions
  • 7.18.4 Asymchem Bio-coupling Drug Outsourcing Services Revenue (US$ Million) & (2020-2025)
  • 7.18.5 Asymchem Recent Developments
• 7.19 Porton Pharma Solutions
  • 7.19.1 Porton Pharma Solutions Profile
  • 7.19.2 Porton Pharma Solutions Main Business
  • 7.19.3 Porton Pharma Solutions Bio-coupling Drug Outsourcing Services Products, Services and Solutions
  • 7.19.4 Porton Pharma Solutions Bio-coupling Drug Outsourcing Services Revenue (US$ Million) & (2020-2025)
  • 7.19.5 Porton Pharma Solutions Recent Developments

8 Industry Chain Analysis

• 8.1 Bio-coupling Drug Outsourcing Services Industrial Chain
• 8.2 Bio-coupling Drug Outsourcing Services Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Bio-coupling Drug Outsourcing Services Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Bio-coupling Drug Outsourcing Services Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer

List of Tables

Table 1. Bio-coupling Drug Outsourcing Services Market Trends

Table 2. Bio-coupling Drug Outsourcing Services Market Drivers & Opportunity

Table 3. Bio-coupling Drug Outsourcing Services Market Challenges

Table 4. Bio-coupling Drug Outsourcing Services Market Restraints

Table 5. Global Bio-coupling Drug Outsourcing Services Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Bio-coupling Drug Outsourcing Services Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Bio-coupling Drug Outsourcing Services Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Bio-coupling Drug Outsourcing Services Product Type

Table 9. Key Companies Time to Begin Mass Production of Bio-coupling Drug Outsourcing Services

Table 10. Global Bio-coupling Drug Outsourcing Services Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio-coupling Drug Outsourcing Services as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Bio-coupling Drug Outsourcing Services Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Bio-coupling Drug Outsourcing Services Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Bio-coupling Drug Outsourcing Services Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Bio-coupling Drug Outsourcing Services Sales Market Share in Value by Type (2020-2025)

Table 17. Global Bio-coupling Drug Outsourcing Services Sales Market Share in Value by Type (2026-2031)

Table 18. Global Bio-coupling Drug Outsourcing Services Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Bio-coupling Drug Outsourcing Services Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Bio-coupling Drug Outsourcing Services Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Bio-coupling Drug Outsourcing Services Sales Market Share in Value by Application (2020-2025)

Table 22. Global Bio-coupling Drug Outsourcing Services Sales Market Share in Value by Application (2026-2031)

Table 23. Global Bio-coupling Drug Outsourcing Services Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Bio-coupling Drug Outsourcing Services Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Bio-coupling Drug Outsourcing Services Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Bio-coupling Drug Outsourcing Services Sales Value by Region (2020-2025) & (%)

Table 27. Global Bio-coupling Drug Outsourcing Services Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Bio-coupling Drug Outsourcing Services Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Bio-coupling Drug Outsourcing Services Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Bio-coupling Drug Outsourcing Services Sales Value, (2026-2031) & (US$ Million)

Table 31. Lonza Basic Information List

Table 32. Lonza Description and Business Overview

Table 33. Lonza Bio-coupling Drug Outsourcing Services Products, Services and Solutions

Table 34. Revenue (US$ Million) in Bio-coupling Drug Outsourcing Services Business of Lonza (2020-2025)

Table 35. Lonza Recent Developments

Table 36. BSP Pharmaceuticals Basic Information List

Table 37. BSP Pharmaceuticals Description and Business Overview

Table 38. BSP Pharmaceuticals Bio-coupling Drug Outsourcing Services Products, Services and Solutions

Table 39. Revenue (US$ Million) in Bio-coupling Drug Outsourcing Services Business of BSP Pharmaceuticals (2020-2025)

Table 40. BSP Pharmaceuticals Recent Developments

Table 41. Catalent Basic Information List

Table 42. Catalent Description and Business Overview

Table 43. Catalent Bio-coupling Drug Outsourcing Services Products, Services and Solutions

Table 44. Revenue (US$ Million) in Bio-coupling Drug Outsourcing Services Business of Catalent (2020-2025)

Table 45. Catalent Recent Developments

Table 46. Merck Basic Information List

Table 47. Merck Description and Business Overview

Table 48. Merck Bio-coupling Drug Outsourcing Services Products, Services and Solutions

Table 49. Revenue (US$ Million) in Bio-coupling Drug Outsourcing Services Business of Merck (2020-2025)

Table 50. Merck Recent Developments

Table 51. WuXi XDC Cayman Inc Basic Information List

Table 52. WuXi XDC Cayman Inc Description and Business Overview

Table 53. WuXi XDC Cayman Inc Bio-coupling Drug Outsourcing Services Products, Services and Solutions

Table 54. Revenue (US$ Million) in Bio-coupling Drug Outsourcing Services Business of WuXi XDC Cayman Inc (2020-2025)

Table 55. WuXi XDC Cayman Inc Recent Developments

Table 56. Thermo Fisher Scientific Basic Information List

Table 57. Thermo Fisher Scientific Description and Business Overview

Table 58. Thermo Fisher Scientific Bio-coupling Drug Outsourcing Services Products, Services and Solutions

Table 59. Revenue (US$ Million) in Bio-coupling Drug Outsourcing Services Business of Thermo Fisher Scientific (2020-2025)

Table 60. Thermo Fisher Scientific Recent Developments

Table 61. Samsung Biologics Basic Information List

Table 62. Samsung Biologics Description and Business Overview

Table 63. Samsung Biologics Bio-coupling Drug Outsourcing Services Products, Services and Solutions

Table 64. Revenue (US$ Million) in Bio-coupling Drug Outsourcing Services Business of Samsung Biologics (2020-2025)

Table 65. Samsung Biologics Recent Developments

Table 66. Recipharm Basic Information List

Table 67. Recipharm Description and Business Overview

Table 68. Recipharm Bio-coupling Drug Outsourcing Services Products, Services and Solutions

Table 69. Revenue (US$ Million) in Bio-coupling Drug Outsourcing Services Business of Recipharm (2020-2025)

Table 70. Recipharm Recent Developments

Table 71. Axplora Basic Information List

Table 72. Axplora Description and Business Overview

Table 73. Axplora Bio-coupling Drug Outsourcing Services Products, Services and Solutions

Table 74. Revenue (US$ Million) in Bio-coupling Drug Outsourcing Services Business of Axplora (2020-2025)

Table 75. Axplora Recent Developments

Table 76. Sterling Pharmaceuticals, Basic Information List

Table 77. Sterling Pharmaceuticals, Description and Business Overview

Table 78. Sterling Pharmaceuticals, Bio-coupling Drug Outsourcing Services Products, Services and Solutions

Table 79. Revenue (US$ Million) in Bio-coupling Drug Outsourcing Services Business of Sterling Pharmaceuticals, (2020-2025)

Table 80. Sterling Pharmaceuticals, Recent Developments

Table 81. NJ Bio, Inc Basic Information List

Table 82. NJ Bio, Inc Description and Business Overview

Table 83. NJ Bio, Inc Bio-coupling Drug Outsourcing Services Products, Services and Solutions

Table 84. Revenue (US$ Million) in Bio-coupling Drug Outsourcing Services Business of NJ Bio, Inc (2020-2025)

Table 85. NJ Bio, Inc Recent Developments

Table 86. Piramal Grangemouth Basic Information List

Table 87. Piramal Grangemouth Description and Business Overview

Table 88. Piramal Grangemouth Bio-coupling Drug Outsourcing Services Products, Services and Solutions

Table 89. Revenue (US$ Million) in Bio-coupling Drug Outsourcing Services Business of Piramal Grangemouth (2020-2025)

Table 90. Piramal Grangemouth Recent Developments

Table 91. Abzena Basic Information List

Table 92. Abzena Description and Business Overview

Table 93. Abzena Bio-coupling Drug Outsourcing Services Products, Services and Solutions

Table 94. Revenue (US$ Million) in Bio-coupling Drug Outsourcing Services Business of Abzena (2020-2025)

Table 95. Abzena Recent Developments

Table 96. Fleet Bioprocessing Basic Information List

Table 97. Fleet Bioprocessing Description and Business Overview

Table 98. Fleet Bioprocessing Bio-coupling Drug Outsourcing Services Products, Services and Solutions

Table 99. Revenue (US$ Million) in Bio-coupling Drug Outsourcing Services Business of Fleet Bioprocessing (2020-2025)

Table 100. Fleet Bioprocessing Recent Developments

Table 101. MabPlex international Basic Information List

Table 102. MabPlex international Description and Business Overview

Table 103. MabPlex international Bio-coupling Drug Outsourcing Services Products, Services and Solutions

Table 104. Revenue (US$ Million) in Bio-coupling Drug Outsourcing Services Business of MabPlex international (2020-2025)

Table 105. MabPlex international Recent Developments

Table 106. Toyo Pharm Basic Information List

Table 107. Toyo Pharm Description and Business Overview

Table 108. Toyo Pharm Bio-coupling Drug Outsourcing Services Products, Services and Solutions

Table 109. Revenue (US$ Million) in Bio-coupling Drug Outsourcing Services Business of Toyo Pharm (2020-2025)

Table 110. Toyo Pharm Recent Developments

Table 111. Aobak Basic Information List

Table 112. Aobak Description and Business Overview

Table 113. Aobak Bio-coupling Drug Outsourcing Services Products, Services and Solutions

Table 114. Revenue (US$ Million) in Bio-coupling Drug Outsourcing Services Business of Aobak (2020-2025)

Table 115. Aobak Recent Developments

Table 116. Asymchem Basic Information List

Table 117. Asymchem Description and Business Overview

Table 118. Asymchem Bio-coupling Drug Outsourcing Services Products, Services and Solutions

Table 119. Revenue (US$ Million) in Bio-coupling Drug Outsourcing Services Business of Asymchem (2020-2025)

Table 120. Asymchem Recent Developments

Table 121. Porton Pharma Solutions Basic Information List

Table 122. Porton Pharma Solutions Description and Business Overview

Table 123. Porton Pharma Solutions Bio-coupling Drug Outsourcing Services Products, Services and Solutions

Table 124. Revenue (US$ Million) in Bio-coupling Drug Outsourcing Services Business of Porton Pharma Solutions (2020-2025)

Table 125. Porton Pharma Solutions Recent Developments

Table 126. Key Raw Materials Lists

Table 127. Raw Materials Key Suppliers Lists

Table 128. Bio-coupling Drug Outsourcing Services Downstream Customers

Table 129. Bio-coupling Drug Outsourcing Services Distributors List

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

List of Figures

Figure 1. Bio-coupling Drug Outsourcing Services Product Picture

Figure 2. Global Bio-coupling Drug Outsourcing Services Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Bio-coupling Drug Outsourcing Services Sales Value (2020-2031) & (US$ Million)

Figure 4. Bio-coupling Drug Outsourcing Services Report Years Considered

Figure 5. Global Bio-coupling Drug Outsourcing Services Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Bio-coupling Drug Outsourcing Services Revenue in 2024

Figure 7. Bio-coupling Drug Outsourcing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Antibody Drug Coupling Outsourcing Services Picture

Figure 9. Dual Anticoupling Material Outsourcing Services Picture

Figure 10. Antibody Oligonucleotide Coupling Outsourcing Services Picture

Figure 11. Others Picture

Figure 12. Global Bio-coupling Drug Outsourcing Services Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 13. Global Bio-coupling Drug Outsourcing Services Sales Value Market Share by Type, 2024 & 2031

Figure 14. Product Picture of Tumor Treatment

Figure 15. Product Picture of Autoimmune Disease Treatment

Figure 16. Product Picture of Treatment of Metabolic Disorders

Figure 17. Product Picture of Others

Figure 18. Global Bio-coupling Drug Outsourcing Services Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 19. Global Bio-coupling Drug Outsourcing Services Sales Value Market Share by Application, 2024 & 2031

Figure 20. North America Bio-coupling Drug Outsourcing Services Sales Value (2020-2031) & (US$ Million)

Figure 21. North America Bio-coupling Drug Outsourcing Services Sales Value by Country (%), 2024 VS 2031

Figure 22. Europe Bio-coupling Drug Outsourcing Services Sales Value, (2020-2031) & (US$ Million)

Figure 23. Europe Bio-coupling Drug Outsourcing Services Sales Value by Country (%), 2024 VS 2031

Figure 24. Asia Pacific Bio-coupling Drug Outsourcing Services Sales Value, (2020-2031) & (US$ Million)

Figure 25. Asia Pacific Bio-coupling Drug Outsourcing Services Sales Value by Region (%), 2024 VS 2031

Figure 26. South America Bio-coupling Drug Outsourcing Services Sales Value, (2020-2031) & (US$ Million)

Figure 27. South America Bio-coupling Drug Outsourcing Services Sales Value by Country (%), 2024 VS 2031

Figure 28. Middle East & Africa Bio-coupling Drug Outsourcing Services Sales Value, (2020-2031) & (US$ Million)

Figure 29. Middle East & Africa Bio-coupling Drug Outsourcing Services Sales Value by Country (%), 2024 VS 2031

Figure 30. Key Countries/Regions Bio-coupling Drug Outsourcing Services Sales Value (%), (2020-2031)

Figure 31. United States Bio-coupling Drug Outsourcing Services Sales Value, (2020-2031) & (US$ Million)

Figure 32. United States Bio-coupling Drug Outsourcing Services Sales Value by Type (%), 2024 VS 2031

Figure 33. United States Bio-coupling Drug Outsourcing Services Sales Value by Application (%), 2024 VS 2031

Figure 34. Europe Bio-coupling Drug Outsourcing Services Sales Value, (2020-2031) & (US$ Million)

Figure 35. Europe Bio-coupling Drug Outsourcing Services Sales Value by Type (%), 2024 VS 2031

Figure 36. Europe Bio-coupling Drug Outsourcing Services Sales Value by Application (%), 2024 VS 2031

Figure 37. China Bio-coupling Drug Outsourcing Services Sales Value, (2020-2031) & (US$ Million)

Figure 38. China Bio-coupling Drug Outsourcing Services Sales Value by Type (%), 2024 VS 2031

Figure 39. China Bio-coupling Drug Outsourcing Services Sales Value by Application (%), 2024 VS 2031

Figure 40. Japan Bio-coupling Drug Outsourcing Services Sales Value, (2020-2031) & (US$ Million)

Figure 41. Japan Bio-coupling Drug Outsourcing Services Sales Value by Type (%), 2024 VS 2031

Figure 42. Japan Bio-coupling Drug Outsourcing Services Sales Value by Application (%), 2024 VS 2031

Figure 43. South Korea Bio-coupling Drug Outsourcing Services Sales Value, (2020-2031) & (US$ Million)

Figure 44. South Korea Bio-coupling Drug Outsourcing Services Sales Value by Type (%), 2024 VS 2031

Figure 45. South Korea Bio-coupling Drug Outsourcing Services Sales Value by Application (%), 2024 VS 2031

Figure 46. Southeast Asia Bio-coupling Drug Outsourcing Services Sales Value, (2020-2031) & (US$ Million)

Figure 47. Southeast Asia Bio-coupling Drug Outsourcing Services Sales Value by Type (%), 2024 VS 2031

Figure 48. Southeast Asia Bio-coupling Drug Outsourcing Services Sales Value by Application (%), 2024 VS 2031

Figure 49. India Bio-coupling Drug Outsourcing Services Sales Value, (2020-2031) & (US$ Million)

Figure 50. India Bio-coupling Drug Outsourcing Services Sales Value by Type (%), 2024 VS 2031

Figure 51. India Bio-coupling Drug Outsourcing Services Sales Value by Application (%), 2024 VS 2031

Figure 52. Bio-coupling Drug Outsourcing Services Industrial Chain

Figure 53. Bio-coupling Drug Outsourcing Services Manufacturing Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed